| Identification | Back Directory | [Name]
Carbamimidothioic acid, [4-[(5,7-dibromo-2,3-dihydro-2,3-dioxo-1H-indol-1-yl)methyl]phenyl]methyl ester, hydrobromide (1:1) | [CAS]
2408477-54-1 | [Synonyms]
KS100
Carbamimidothioic acid, [4-[(5,7-dibromo-2,3-dihydro-2,3-dioxo-1H-indol-1-yl)methyl]phenyl]methyl ester, hydrobromide (1:1) | [Molecular Formula]
C17H14Br3N3O2S | [MOL File]
2408477-54-1.mol | [Molecular Weight]
564.09 |
| Hazard Information | Back Directory | [Uses]
KS100 is a potent ALDH inhibitor with IC50s of 230, 1542, 193 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS100 shows antiproliferative and anticancer effects with low low toxic. KS100 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS10600 induces apoptosis and cell cycle arrest at the G2/M phase[1]. | [References]
[1] Dinavahi SS, et al. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents. Eur J Med Chem. 2020 Feb 1;187:111962. DOI:10.1016/j.ejmech.2019.111962 |
|
|